Effect of serum uric acid level on maternal and neonatal outcome in patients with hypertensive disorders of pregnancy at HSK Hospital, Bagalkot: A prospective and observational study

Authors

DOI:

https://doi.org/10.3126/ajms.v13i12.47723

Keywords:

Gestational hypertension; Uric acid; Pregnancy outcome; Hemolytic anemia elevated liver enzymes levels, Low platelet count syndrome

Abstract

Background: Uric acid, a metabolite of purine metabolism, is considered as a marker of hypertensive disorder of pregnancy (HDP) severity. An increase in serum uric acid level in pregnant mothers has been found to be associated with the disease severity.

Aims and Objectives: The present study intended to evaluate the effect of serum uric acid level in maternal and neonatal outcome in cases of hypertensive disorders of pregnancy.

Materials and Methods: This prospective and observational study was conducted on patients with HDP from December 2017 to April 2019. The study was conducted on 274 subjects who visited the Department of Obstetrics and Gynecology, HSK Hospital, Bagalkot. The participants were categorized into two groups according to their serum uric acid level (<6 mg/dL and ≥6 mg/dL). Serum uric acid was estimated by enzymatic colorimetric method. Maternal and neonatal outcomes were recorded. Follow-up was done till the discharge of the mother and child from the hospital. Data were analyzed using coGuide software.

Results: The majority of the participants were in the age group of 18–23 year (52.91%). No significant association was observed between serum uric acid groups and maternal parameters such asparity, gestational age, onset of labor, mode of delivery, and maternal complications (P>0.05). There was statistically no significant difference between serum uric acid groups in neonatal outcomes such as Apgar score 1 min and 5 min, IGUR, NICU admission, and reason for NICU admission (P>0.05) except for still birth. Still birth was found to be more in patients with serum uric acid ≥6mg/dl (19.64%) group compared to <6 mg/dl (8.64%) with P=0.008.

Conclusion: This study shows that there was no significant association between adverse maternal and neonatal outcomes with increased level of serum uric acid.

Downloads

Download data is not yet available.
Abstract
76
PDF
130

Downloads

Published

2022-12-01

How to Cite

Neel Prajapati, Sujay Heranjal, Varsha Chakrakodi Raghuram, Santosh Rathod, & Ashalata Mallapur. (2022). Effect of serum uric acid level on maternal and neonatal outcome in patients with hypertensive disorders of pregnancy at HSK Hospital, Bagalkot: A prospective and observational study. Asian Journal of Medical Sciences, 13(12), 55–60. https://doi.org/10.3126/ajms.v13i12.47723

Issue

Vol. 13 No. 12 (2022)

Section

Original Articles

License

Copyright (c) 2022 Asian Journal of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).